Prescribing high-risk birth control pills



We are searching data for your request:

Forums and discussions:
Manuals and reference books:
Data from registers:
Wait the end of the search in all databases.
Upon completion, a link will appear to access the found materials.

Unnecessarily high risk of thrombosis due to birth control pills
Drug report criticizes prescribing practice for birth control pills

When presenting the Pharmaceutical Report 2011 of the Barmer GEK, the health economist Professor Doctor Gerd Glaeske from the Center for Social Policy at the University of Bremen pointed out numerous abuses regarding the prescription of medication. In addition to the over-medication of dementia patients, the expert criticized above all the prescribing practice in the area of ​​birth control pills. According to the Bremen health economist, young healthy women are often unnecessarily exposed to a significantly increased risk of thrombosis.

The 2011 Pharmaceutical Report comes to the conclusion that when prescribing birth control pills, products are often used that pose a thrombosis risk that is around twice as high as that of other drugs. Professor Doctor Gerd Glaeske suspects that this is essentially due to the economic interests of the pharmaceutical companies. Since the patents of older contraceptive pills of the second generation, which entail a significantly lower risk of thrombosis, have expired or have expired, the riskier contraceptive pills of the third and fourth generation are advertised instead, according to the expert. As with the over-medication of dementia patients, economic considerations are made about the health needs of patients, the Bremen health economist criticized when presenting the 2011 pharmaceutical report of the Barmer GEK in Berlin on Wednesday.

Birth control pills generally cause an increased risk of thrombosis Women who use contraceptive pills generally expose themselves to an increased risk of thrombosis, but only 15 to 20 out of 100,000 women with the older preparations of the second generation of pills suffer more than one year of use a thrombosis, whereas the more modern third and fourth generation birth control pills show 30 to 40 dangerous thrombosis cases, said Glaeske. According to the expert, the fact that the newer preparations still make up around half of the prescriptions is due to the fact that the patents for the older pills have expired and the profit margin has therefore decreased significantly. Instead, the pharmaceutical companies are trying to promote their newer, lucrative products to women through extensive advertising measures. These advertising measures have an effect on both patients and doctors, according to the joint accusation of the Barmer GEK and the Bremen health economist.

Medical associations and pharmaceutical companies reject allegations The medical associations and pharmaceutical companies immediately defended themselves against the implied allegations of the 2011 pharmaceutical report and dismissed the criticism as unjustified. The doctors contested a possible connection between prescribing practice and marketing efforts by pharmaceutical companies. "It is perfidious to design a blanket picture of the fact that doctors prescribe irresponsibly," Roland Stahl, spokesman for the National Association of Statutory Health Insurance Physicians, told the Hamburger Abendblatt. The medical associations vehemently denied a preference for the more lucrative but also riskier modern contraceptive pill. In general, the responsible physicians would base their prescriptions on the current medical guidelines, so that the scope was inherently tight. The pharmaceutical companies, on the other hand, pointed out that with all birth control pills there is a risk of thrombosis, which is only subject to insignificant differences. "All birth control pills have the characteristic that they slightly increase the risk of thrombosis (...) some more, others a little less," said the spokesman for the Association of Research-Based Pharmaceutical Manufacturers, Rolf Hömke in an interview with the "Hamburger Abendblatt".

Women should inform themselves well before using the birth control pill. It is understandable from a business perspective that the pharmaceutical companies are trying to market their newer, more lucrative birth control pills, but in the interests of the patients, a comprehensive explanation of the advantages and disadvantages of the various preparations should be given the Prof. Dr. Glaeske at the presentation of the drug report. Thereby, the treating physicians are primarily required to enable the patients to make their own judgments. So far, however, the profitable birth control pills of the third and fourth generation have been massively advertised by the pharmaceutical companies, while their disadvantages are rarely mentioned, according to the criticism of the Bremen health economist and author of the drug report 2011. According to Glaeske, it is still “the fact that this The market is not in favor of women. ”The expert therefore advises women who want to use the pill to prevent them from getting intensive information from their doctor about possible risks of the various preparations, while also taking into account the different risk of thrombosis to let. (fp)

Also read:
Pharmacies should dispose of old medicines
Pharmaceutical company stops Viagra for women
Homeopathy is free from dangerous side effects

Image: Benjamin Klack / pixelio.de

Author and source information



Video: Contraception course - the new pill start consultation in detail


Comments:

  1. Dailmaran

    It is better if you write about what you know for sure and have tried it on your own experience, otherwise you are pouring water that is meaningless in essence

  2. Chappell

    I think you are not right. I can prove it. Write to me in PM, we will discuss.

  3. Matthias

    It happens ... such a coincidence

  4. Drem

    Certainly. So it happens.



Write a message


Previous Article

Doctors prescribe more remedies than before

Next Article

PKV cost trap: How affected people can defend themselves